Downtrend on the daily chart: below its 50- and 200-day averages · 50-day below the 200-day · SuperTrend down since Mar 2 · below the Ichimoku cloud · RSI 48 · MACD above its signal · 10% above its 52-week low
None of the 29 investors followed here reported a position in 3309.HK in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a 3309.HK trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
No insider transactions reported for 3309.HK.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -11.0 | -3.3 | -12.8 | -4.7 | -13.8 | -11.3 | -1.1 | -10.2 | -6.6 | 2.6 | −53.5% | ||
| 2025 | -4.0 | -9.3 | -10.3 | 7.6 | 0.6 | 5.9 | 1.1 | 10.4 | 1.0 | -10.3 | -4.4 | -1.1 | −14.4% |
| 2024 | -23.3 | 15.5 | -7.2 | 4.9 | -0.7 | -5.8 | -5.8 | -15.3 | 26.6 | -18.5 | -11.4 | -1.0 | −41.6% |
| 2023 | 0.0 | -5.9 | 0.0 | -2.8 | -14.1 | -1.8 | 6.9 | -8.7 | 3.3 | 0.3 | -5.5 | -4.7 | −29.8% |
| 2022 | -22.5 | 1.9 | -15.1 | -6.5 | 5.6 | 7.7 | -18.5 | 0.8 | -14.6 | -5.5 | 24.9 | 20.7 | −28.9% |
| 2021 | 9.1 | -5.6 | -7.1 | 7.7 | 6.6 | 58.4 | -24.0 | 3.2 | 2.2 | -4.6 | -10.1 | 0.6 | +20.0% |
| 2020 | -8.8 | -1.8 | -2.0 | -9.3 | 60.4 | 3.7 | -2.4 | 2.5 | -14.8 | -7.8 | 15.5 | -4.8 | +14.6% |
| 2019 | 0.8 | 1.8 | -3.1 | -8.0 | -7.4 | 2.6 | 10.3 | 0.8 | 5.6 | 1.4 | -5.8 | 2.2 | −0.4% |
| 2018 | 0.7 | -13.2 | -11.8 | 4.5 | -11.1 | -15.8 | -24.8 | -16.4 | -23.3 | 76.2 | -14.0 | −56.0% |
No analyst coverage for this instrument.
C-MER Medical Holdings Limited, an investment holding company, provides ophthalmic services under the C-MER Dennis Lam brand name in Hong Kong and Mainland China. It operates through five segments: HK Medical Business, Mainland China Ophthalmic Business, Mainland China Dental Business, and Mainland China Other Business. The company provides oncology, medical aesthetics, general practice, ophthalmic, dental, and other medical services; cataract, glaucoma, strabismus and refractive surgeries, external eye diseases, and vitreoretinal disease services; and medical consumables. It also engages in the sale of vision aid products, such as glasses and lens. The company was formerly known as C-MER Eye Care Holdings Limited and changed its name to C-MER Medical Holdings Limited in June 2024. The company was founded in 2012 and is headquartered in Central, Hong Kong. C-MER Medical Holdings Limited is a subsidiary of C-MER Group Limited.
No recent headlines.